[Retracted] Expression of CX3CL1 and CCL28 in Spinal Metastases of Lung Adenocarcinoma and Their Correlation with Clinical Features and Prognosis

Table 1

Correlation between different expression levels of cx3cl1 and CCL28 and clinical data.

Characteristics			CX3CL1			P	CCL28			P
			-/+ (%)	++ (%)	+++ (%)		-/+(%)	++(%)	+++(%)
Gender	Female	21	4 (19.0)	14 (66.7)	3 (14.3)	0.592	3 (14.3)	15 (71.4)	3 (14.3)	0.549
	Male	19	4 (21.1)	11 (57.9)	4 (21.1)		2 (10.5)	12 (63.2)	5 (26.3)
Age (years)	≥60	30	6 (20.0)	19 (63.3)	5 (16.7)	0.688	4 (13.3)	21 (70.0)	5 (16.7)	0.633
	<60	10	2 (20.0)	6 (60.0)	2 (20.0)		1 (10.0)	6 (60.0)	3 (30.0)
Number of bonemetastases	Single	8	3 (37.5)	3 (37.5)	2 (25.0)	0.320	4 (50.0)	2 (25.0)	2 (25.0)	0.507
	Multiple	32	5 (15.6)	22 (68.75)	5 (15.6)		1 (3.1)	25 (78.1)	6 (18.8)
ECOG scores	0–2	12	6 (50.0)	4 (33.3)	2 (16.6)	0.005	4 (33.3)	6 (50.0)	2 (16.7)	0.022
	3–4	28	2 (7.1)	21 (75)	5 (17.9)		1 (3.6)	21 (75.0)	6 (21.4)
Chemotherapy	No	17	2 (11.8)	10 (58.9)	5 (29.4)	0.428	2 (11.8)	13 (76.5)	2 (11.8)	0.646
	Yes	23	6 (26.1)	15 (65.2)	2 (8.7)		3 (13.0)	14 (60.9)	6 (26.1)
Visceral metastasis	No	8	5 (62.5)	2 (25.0)	1 (12.5)	0.004	4 (50.0)	2 (25.0)	2 (25.0)	0.003
	Yes	32	3 (9.4)	23 (71.9)	6 (18.8)		1 (3.1)	25 (78.1)	6 (18.8)

P＜0.05, indicating statistical significance.